The pathogenesis of acne is not completely understood, but the current consensus is that it involves four major events: follicular hyperconification, increased sebum production, colonization of Propionibacterium acnes (P. acnes), and inflammation (Lee et al., 2007b). P. acnes plays a major role in the development of acne by acting on triglycerides and releasing cytokines, which results in inflammatory reactions, and alters infundibular keratinization (Lee et al., 2007b).
Current therapeutic options for acne vulgaris include topical antibiotics (e.g., clindamycin and erythromycin), topical retinoids (e.g., tretinoin and adapalene), benzoyl peroxide, alpha hydroxy acids (AHA), salicylic acid, and azelaic acid. In severe cases, administration of antibiotics (e.g., tetracycline, doxycycline online), oral retinoids, and certain hormonal treatments is recommended (Aziz-Jalali et al., 2012).
Most medications work by counteracting microcomedone formation, sebum production, P. acnes, and inflammation (Aziz-Jalali et al., 2012). Despite the many treatment options currently available, several patients still show an inadequate response to the treatment, while others suffer from actual adverse effects.
The sebaceous gland is colonized by bacteria, which can be killed by blue light due to the endogenous porphyrins they produce, acting as photosensitizers and forming reactive oxygen species. Red light can reduce inflammation and stimulate healing with minimal scarring.
One study demonstrated a significant reduction in active acne lesions after 12 sessions of treatment, using 630 nm red spectrum LLLT with a fluence of 12 J/cm2, twice a week for 12 sessions in conjunction with 2% topical clindamycin (Aziz-Jalali et al., 2012). However, the study showed no significant effects when an 890 nm laser was used (Aziz-Jalali et al., 2012).
It was proposed that, the enhanced effects of mixed light were due to synergy between the anti-bacterial and anti-inflammatory effects of blue light and red light respectively (Lee et al., 2007b; Papageorgiou et al., 2000) (Figure 2). In several studies, improvements in inflammatory lesions were reported to be greater than the improvements in comedones (Lee et al., 2007b; Papageorgiou et al., 2000).